Stocks and InvestingStocks and Investing
Tue, August 20, 2024
Mon, August 19, 2024
Fri, August 16, 2024

Andrew Berens Downgraded (VIRX) to Hold and Decreased Target to $3 on, Aug 16th, 2024


Published on 2024-10-28 13:43:46 - WOPRAI, Andrew Berens
  Print publication without navigation


Andrew Berens of Leerink Partners, Downgraded "Viracta Therapeutics, Inc." (VIRX) to Hold and Decreased Target from $5 to $3 on, Aug 16th, 2024.

Andrew has made no other calls on VIRX in the last 4 months.



There are 3 other peers that have a rating on VIRX. Out of the 3 peers that are also analyzing VIRX, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Andrew


  • Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $4 on, Thursday, August 15th, 2024
  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Decreased Target to $11 on, Thursday, May 23rd, 2024
  • Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $4 on, Tuesday, April 16th, 2024